| 409 - 416 |
Development of photostable gastro retentive formulation for nifedipine using low-density polypropylene microporous particles
Pawar AP, Shelake MR, Bothiraja C, Kamble RN |
| 417 - 428 |
Effects of process variables on the encapsulation of oil in ca-alginate capsules using an inverse gelation technique
Abang S, Chan ES, Poncelet D |
| 429 - 436 |
Effect of microencapsulation of Lactobacillus salivarus 29 into alginate/chitosan/alginate microcapsules on viability and cytokine induction
Bajracharya P, Islam MA, Jiang T, Kang SK, Choi YJ, Cho CS |
| 437 - 444 |
Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy
Zheng YY, Zhang YP, Ao M, Zhang P, Zhang H, Li P, Qing L, Wang ZG, Ran HT |
| 445 - 454 |
Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis
Sultana S, Talegaonkar S, Ali R, Mittal G, Ahmad FJ, Bhatnagar A |
| 455 - 462 |
Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition
Oettinger CW, D'Souza MJ |
| 463 - 474 |
Determination of the shell permeability of microcapsules with a core of oil-based active ingredient
Mercade-Prieto R, Allen R, York D, Preece JA, Goodwin TE, Zhang ZB |
| 475 - 486 |
Delivery of drugs to the brain via the blood brain barrier using colloidal carriers
Tucker IG, Yang L, Mujoo H |
| 487 - 496 |
Surface-modified gemcitabine with mucoadhesive polymer for oral delivery
Lim JH, You SK, Baek JS, Hwang CJ, Na YG, Shin SC, Cho CW |
| 497 - 504 |
Development of poly(glycerol adipate) nanoparticles loaded with non-steroidal anti-inflammatory drugs
Wahab A, Favretto ME, Onyeagor ND, Khan GM, Douroumis D, Casely-Hayford MA, Kallinteri P |
| 505 - 510 |
Development of miconazole nitrate containing chitosan microcapsules and their anti-Aspergillus niger activity
Yuen CWM, Kan CW, Cheuk KL, Cheung HC, Cheng SY, Yip J, Lam PL |
